Search

everythinglearnresearchcommunity

for

Search:↓

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

MicroRNA-21 could help diagnose and treat skin fibrosis.

ACBP is crucial for healthy skin in mice.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Scaffold-based strategies show promise for regenerating hair follicles and teeth but need more research for clinical use.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Mutations in NIPAL4 cause skin issues by disrupting lipid layers, but some improvement is seen with topical treatment.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

New cancer treatments aim to reduce side effects and improve effectiveness.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

A woman's hair loss led to discovering she had lupus.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Patients with hidradenitis suppurativa have higher levels of cell-free DNA in their blood.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

A patient with a scalp condition and benign skin tumor experienced hair loss and did not improve with treatment, choosing not to have surgery despite a small cancer risk.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Experts met to improve care for ichthyosis patients in Spain.

Skin, hair, and nail changes can help detect eating disorders early.

Educating primary care doctors and improving referrals to rheumatologists can reduce delays in treating lupus patients.

Early recognition and treatment of SLE can improve outcomes in patients with complex symptoms.

PRP shows promise but lacks consistent evidence and regulation.